Interface(TILE) - 2025 Q4 - Earnings Call Transcript

Financial Data and Key Metrics Changes - In 2025, the company achieved record net sales, Adjusted Operating Income, and Adjusted EBITDA, with currency-neutral net sales increasing by 4% year-over-year [4][14] - Full year net sales totaled $1.39 billion, up 5.4%, with currency-neutral net sales in the Americas increasing by 5.5% and in EAAA by 2.4% [21][22] - Adjusted gross profit margin increased to 39%, up 187 basis points, driven by favorable pricing and manufacturing efficiencies [22] - Adjusted EPS for the fourth quarter was $0.49, up 44.1% compared to $0.34 [19] Business Line Data and Key Metrics Changes - All three product categories (carpet tile, LVT, and nora Rubber) experienced growth in both price and volume [5] - Global rubber billings increased by 17% in 2025 compared to the prior year [6] - Healthcare billings were up 21% year-over-year, while education billings increased by 8% [14][15] Market Data and Key Metrics Changes - In the Americas, currency-neutral net sales increased by 5% year-over-year, particularly strong in healthcare and education segments [14] - EAAA region saw a 2% increase in currency-neutral net sales, reflecting improving trends despite a challenging macro environment [14] - Corporate office billings were slightly up, with a focus on Class A spaces [15] Company Strategy and Development Direction - The company is committed to the "One Interface" strategy, focusing on global functions to support local selling teams and enhancing commercial productivity [4] - Continued investments in automation and robotics are expected to drive productivity gains and margin expansion [7][8] - The launch of Noravant, a new rubber flooring innovation, aims to expand the addressable market in the resilient category [9][10] Management's Comments on Operating Environment and Future Outlook - Management expressed confidence in the scalability of the combined selling team model, particularly in healthcare and education [7] - The company anticipates continued growth driven by strong demand in healthcare and education, supported by macro tailwinds [15][16] - For 2026, the company expects net sales of $1.42 billion to $1.46 billion, with an adjusted gross profit margin of approximately 38.5%-39% [28][29] Other Important Information - The company generated $167.9 million in cash from operating activities in 2025, compared to $148.4 million in 2024 [24] - Capital expenditures for 2025 were $46.2 million, with an expected increase to $55 million in 2026 to support automation initiatives [25] - The board approved an increase in the quarterly dividend from $0.02 to $0.03 per share, reflecting confidence in cash flow generation [26] Q&A Session Summary Question: Can you talk about the One Interface selling strategy? - Management highlighted the success of the combined selling teams in the U.S., with healthcare billings up 21% and nora business up 17% [34] Question: Can you discuss gross margins for 2026? - Management noted that gross margins achieved 38.5%, with expectations for continued expansion driven by automation and efficiency initiatives [36][38] Question: How is the corporate market performing compared to healthcare and education? - Management indicated that the corporate business was flat, with retail business being soft, but healthcare and education showed strong growth [46][47] Question: Can you provide details on the backlog increase? - Management described the backlog as solid and well-distributed across initiatives, providing confidence entering 2026 [50][51] Question: How is SG&A being managed while pursuing growth? - Management emphasized disciplined spending and variable compensation tied to revenue, ensuring efficient use of resources [54][55] Question: What is the impact of tariffs on gross margins? - Management indicated that tariffs diluted gross profit percentage by around 20 basis points in 2025, with an anticipated 50 basis points impact in 2026 [91] Question: Can you provide global billings by category for Q4? - Management reported that corporate was flat, education was up 11.6%, and healthcare was up 11.7% [105]